Trials / Not Yet Recruiting
Not Yet RecruitingNCT06075043
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
A Multicenter, Randomized, Open-label Study of AND017 for the Treatment of Anemia of Cancer in Patients Not Receiving Chemotherapy
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Kind Pharmaceuticals LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of various doses of AND017 after 6 weeks of treatment in subjects with anemia of cancer who are not receiving chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AND017 | Oral administration of AND017 capsules three times per week |
Timeline
- Start date
- 2027-12-01
- Primary completion
- 2028-05-01
- Completion
- 2028-08-01
- First posted
- 2023-10-10
- Last updated
- 2026-02-27
Source: ClinicalTrials.gov record NCT06075043. Inclusion in this directory is not an endorsement.